Generated by AI
Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on women’s health. Daré Bioscience develops and commercializes therapies in contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health, with an emphasis on improving treatment options and convenience for women. Its portfolio includes approved and investigational products designed to address unmet needs in reproductive and intimate health, such as non-hormonal contraception, vaginal health treatments, and hormone-related therapies. The company operates as a product-driven biotech business, advancing candidates through clinical development and regulatory pathways in the United States. Headquartered in San Diego, California, Daré Bioscience plays a specialized role in the healthcare market by concentrating on differentiated solutions for areas that are often underrepresented in women’s medicine.
Website3655 Nobel Drive
San Diego, CA, 92122
United States
The latest articles about DARE.
Summary of Nov 16's posts. Generated by AI.
Summary of Apr 16's posts. Generated by AI.
Summary of Jul 14's posts. Generated by AI.
Summary of Aug 14's posts. Generated by AI.
Investors talking about DARE also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.